CompletedNCT02305732

A Prospective, Open Label, Treatment Use Study of Patient Safety Following Transfusion of INTERCEPT Platelet Components

Studying Chikungunya

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Cerus Corporation
Principal Investigator
Susan L Stramer, PhD
American National Red Cross
Intervention
INTERCEPT Platelets(biological)
Enrollment
90 enrolled
Eligibility
All sexes
Timeline
2015 – 2016

Study locations (8)

Collaborators

American National Red Cross

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02305732 on ClinicalTrials.gov

Other trials for Chikungunya

Additional recruiting or active studies for the same condition.

See all trials for Chikungunya →

← Back to all trials